| Aclasta 5 mg solution for infusion EU/1/05/308/001 |
Zoledronic acid |
Sandoz Pharmaceuticals d.d. |
— |
| ATRIANCE 5mg/ml Solution for Infusion EU/1/07/403/001 |
Nelarabine |
Sandoz Pharmaceuticals d.d. |
— |
| Estradot 100 micrograms/24 hours, transdermal patch PA23311/004/004 |
Estradiol |
Sandoz Pharmaceuticals d.d. |
Marketed |
| Estradot 25 micrograms/24 hours, transdermal patch PA23311/004/005 |
Estradiol |
Sandoz Pharmaceuticals d.d. |
Not marketed |
| Estradot 37.5 micrograms/24 hours, transdermal patch PA23311/004/001 |
Estradiol |
Sandoz Pharmaceuticals d.d. |
Marketed |
| Estradot 50 micrograms/24 hours, transdermal patch PA23311/004/002 |
Estradiol |
Sandoz Pharmaceuticals d.d. |
Marketed |
| Estradot 75 micrograms/24 hours, transdermal patch PA23311/004/003 |
Estradiol |
Sandoz Pharmaceuticals d.d. |
Marketed |
| Fortum 1 g powder for solution for injection or infusion PA23311/001/002 |
Ceftazidime |
Sandoz Pharmaceuticals d.d. |
Marketed |
| Fortum 2 g powder for solution for injection or infusion PA23311/001/003 |
Ceftazidime |
Sandoz Pharmaceuticals d.d. |
Marketed |
| Fortum 500 mg powder for solution for injection PA23311/001/001 |
Ceftazidime |
Sandoz Pharmaceuticals d.d. |
Marketed |
| HYCAMTIN 0.25 mg hard capsules EU/1/96/027/006 |
Topotecan hydrochloride |
Sandoz Pharmaceuticals d.d. |
— |
| HYCAMTIN 1 mg hard capsules EU/1/96/027/007 |
Topotecan hydrochloride |
Sandoz Pharmaceuticals d.d. |
— |
| Hycamtin 1 mg powder for concentrate for solution for infusion EU/1/96/027/004 |
Topotecan (as hydrochloride) |
Sandoz Pharmaceuticals d.d. |
— |
| HYCAMTIN 1 mg powder for concentrate for solution for infusion EU/1/96/027/005 |
Topotecan (as hydrochloride) |
Sandoz Pharmaceuticals d.d. |
Marketed |
| Hycamtin 4 mg powder for concentrate for solution for infusion EU/1/96/027/003 |
Topotecan hydrochloride |
Sandoz Pharmaceuticals d.d. |
— |
| HYCAMTIN 4 mg powder for concentrate for solution for infusion EU/1/96/027/001 |
Topotecan hydrochloride |
Sandoz Pharmaceuticals d.d. |
— |
| Mycamine 100 mg powder for solution for infusion EU/1/08/448/002 |
Micafungin sodium |
Sandoz Pharmaceuticals d.d. |
— |
| Mycamine 50 mg powder for concentrate for solution for infusion EU/1/08/448/001 |
Micafungin sodium |
Sandoz Pharmaceuticals d.d. |
— |
| Transiderm-Nitro 10milligram/24 hours Transdermal Patch PA23311/005/002 |
Glyceryl trinitrate |
Sandoz Pharmaceuticals d.d. |
Marketed |
| Transiderm-Nitro 15milligrams/24 hours Transdermal Patch PA23311/005/003 |
Glyceryl trinitrate |
Sandoz Pharmaceuticals d.d. |
Marketed |
| Transiderm-Nitro 5milligrams/24 hours Transdermal Patch PA23311/005/001 |
Glyceryl trinitrate |
Sandoz Pharmaceuticals d.d. |
Marketed |
| Zinacef 1.5 g powder for solution for injection or infusion PA23311/002/003 |
Cefuroxime Sodium |
Sandoz Pharmaceuticals d.d. |
Marketed |
| Zinacef 250 mg powder for solution for injection or infusion PA23311/002/001 |
Cefuroxime Sodium |
Sandoz Pharmaceuticals d.d. |
Marketed |
| Zinacef 750 mg powder for solution for injection or infusion PA23311/002/002 |
Cefuroxime Sodium |
Sandoz Pharmaceuticals d.d. |
Marketed |
| Zinnat 125 mg film-coated tablets PA23311/003/002 |
Cefuroxime |
Sandoz Pharmaceuticals d.d. |
Marketed |
| Zinnat 125 mg/5 ml granules for oral suspension PA23311/003/005 |
Cefuroxime axetil |
Sandoz Pharmaceuticals d.d. |
Marketed |
| Zinnat 250 mg film-coated tablets PA23311/003/003 |
Cefuroxime |
Sandoz Pharmaceuticals d.d. |
Marketed |
| Zinnat 250mg/5ml granules for oral suspension PA23311/003/001 |
Cefuroxime axetil |
Sandoz Pharmaceuticals d.d. |
Marketed |
| Zinnat 500 mg film-coated tablets PA23311/003/004 |
Cefuroxime |
Sandoz Pharmaceuticals d.d. |
Marketed |